Science Explorer Interactive view Map
Company · Lexington · United States

Epix Pharmaceuticals (United States)

epixpharma.comROR OpenAlex
World rank, all time
#21,405
of 42,892
Rank in United States
#4,627
of 8,685
Research works
158
▲ 98% vs 2013–17
Citations
7.1k
44.7 per fractional work
Top-10% rate
12.3%
record average 16.5%
Open access
27%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.13× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.20× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 9.13× its world share, 2 worksImmunology and Micro…Neuroscience: 2.51× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.14× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.19× its world share, 0 worksChemistryComputer Science: 0.28× its world share, 1 worksComputer ScienceEnvironmental Science: 0.25× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.09× its world share, 0 worksMaterials ScienceHealth Professions: 0.47× its world share, 0 worksHealth ProfessionsMedicine: 2.90× its world share, 15 worksMedicineEconomics, Econometrics and Finance: 1.73× its world share, 1 worksEconomics, Econometr…Psychology: 2.14× its world share, 2 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.1×. Every wedge is a field page.

Who are the top researchers at Epix Pharmaceuticals (United States)?

Ranked on the composite score, William P. Forbes lead among researchers whose main affiliation is Epix Pharmaceuticals (United States).

  1. 1 William P. Forbes United States · #797,237 worldwide 34 citations · 32 works
All ranked researchers at Epix Pharmaceuticals (United States)

Which keywords describe research at Epix Pharmaceuticals (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Cancer, Immunotherapy, Cancer Treatment, Angiogenesis, Clinical Trials, Enteric Nervous System and Gene Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 10 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 10 words, with their numbers
  1. Inflammation4▲ 7.6×15 topics
  2. Cancer2▲ 6.0×10 topics
  3. Immunotherapy2▲ 9.7×6 topics
  4. Cancer Treatment2▲ 24×3 topics
  5. Angiogenesis1▲ 14×3 topics
  6. Clinical Trials1▲ 6.8×4 topics
  7. Enteric Nervous System1▲ 93×2 topics
  8. Gene Therapy1▲ 21×3 topics
  9. PET Imaging1▲ 22×2 topics
  10. Targeted Therapy1▲ 17×3 topics

Which research topics does Epix Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Gastrointestinal motility and disorders, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research and RNA Interference and Gene Delivery.

Gastrointestinal motilit…1Gastrointestinal motility and disorders: 1 fractional worksRadiopharmaceutical Chem…1Radiopharmaceutical Chemistry and Applications: 1 fractional worksProstate Cancer Treatmen…1Prostate Cancer Treatment and Research: 1 fractional worksRNA Interference and Gen…1RNA Interference and Gene Delivery: 1 fractional worksImmune Response and Inflammation: 1 fractional worksChemokine receptors and signaling: 1 fractional worksPsychedelics and Drug St…1Psychedelics and Drug Studies: 1 fractional worksCAR-T cell therapy research: 0 fractional worksGalectins and Cancer Biology: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional works
GastroenterologyRadiology, Nuclear Medicine and ImagingPulmonary and Respiratory MedicineMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Gastrointestinal motility and disorders Gastroenterology 1 works
  2. 2 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  4. 4 RNA Interference and Gene Delivery Molecular Biology 1 works
  5. 5 Immune Response and Inflammation Immunology 1 works
  6. 6 Chemokine receptors and signaling Oncology 1 works
  7. 7 Psychedelics and Drug Studies Clinical Psychology 1 works
  8. 8 CAR-T cell therapy research Oncology 0 works
  9. 9 Galectins and Cancer Biology Immunology 0 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.1%not open72.9%

World: 28% of research is openly available.

with international co-authors18.1%domestic only81.9%

World: 19% is written across borders.

How has Epix Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 98% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lexington

All research institutions in Lexington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.